Abstract: A computer-implemented method for locating lost devices may include (1) receiving a report of a lost device that specifies a hardware address that uniquely identifies the lost device, (2) collecting information from a helper device that has been connected to a local area network that indicates that a device with the hardware address of the lost device was observed as being connected to the local area network, (3) receiving location data from the helper device that specifies a location of the helper device, and (4) providing the location of the helper device as a location of the lost device in response to the report. Various other methods and systems are also disclosed.

Abstract: The present invention relates to inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids.

Abstract: The present invention relates to inhibitors of 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids.

Abstract: A power steering apparatus includes: a torque sensor for detecting a steering torque applied to a steering wheel and outputting a torque signal corresponding to the steering torque; a speed sensor for detecting a speed of a vehicle and outputting a speed signal corresponding to the speed of the vehicle; a humidity sensor for outputting a humidity signal corresponding to a humidity of an interior of the power steering apparatus; and an electronic control unit for receiving the humidity signal from the humidity sensor, and for, when a measured humidity is an reference value or higher, generating a motor current signal for supplying an assistant steering force smaller than an assistant force set in response to the torque signal and the speed signal.

Abstract: A method for treating a patient suffering from disorders and deficits of the central nervous system associated with diabetes, associated with aging and neurodegeneration, comprising attention deficit disorder in general, attention deficit hyperactivity disorder (ADHD), Alzheimer's disease (AD), mild cognitive impairment, senile dementia, AIDS dementia, neurodegeneration, depression, and schizophrenia, comprising administering to a patient in need of such treatment an effective amount of a selective inhibitor of the 11-?-hydroxysteroid dehydrogenase Type 1 enzyme activity.

Abstract: The present invention relates to inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids.

Abstract: The present invention relates to inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids.

Abstract: A method for treating a patient suffering from disorders and deficits of the central nervous system associated with diabetes, associated with aging and neurodegeneration, comprising attention deficit disorder in general, attention deficit hyperactivity disorder (ADHD), Alzheimer's disease (AD), mild cognitive impairment, senile dementia, AIDS dementia, neurodegeneration, depression, and schizophrenia, comprising administering to a patient in need of such treatment an effective amount of a selective inhibitor of the 11-?-hydroxysteroid dehydrogenase Type 1 enzyme activity.

Abstract: A rack-driven auxiliary power steering apparatus prevents a ball nut and a nut pulley from idling due to a slip thereof and increases durability when the drive belt is operated by driving of a motor, and minimizes vibrations and noise transferred through the rack bar, the ball nut, and the nut pulley when the rack bar is slid while the nut pulley and the ball nut are rotating, thereby providing a comfortable steering feeling to the driver.

Abstract: The present invention relates to inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids.

Abstract: The present invention relates to compounds which inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II diabetes, as well as hyperglycemia, Syndrome X, hyperinsulinemia, obesity, atherosclerosis, and various immunomodulatory diseases.

Abstract: A rack-assist type electric power steering apparatus, in which when a ball nut slides a rack bar while rotating, a vibration and a noise in the axis direction and the radial direction, generated from the rack bar and a rack housing, are absorbed. This facilitates the operation of the ball nut and the rack bar, and reduces the vibration and the noise, thereby resulting in an effect for providing a comfortable steering feeling to a driver.

Abstract: A rack driving-type power assisted steering apparatus having effects of preventing a lock screw from being loosened due to vibration in axial and radial directions generated by a rack bar, a ball nut, and a rack housing when the rack bar slides while the ball nut rotates, reducing vibration and noise of the ball nut and the rack bar transferred through a bearing, and providing a driver with steering comfortability.

Abstract: The present invention relates to inhibitors of 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids.

Abstract: There is described a process for the manufacture of compounds of the formula I said process comprising reacting a compound of the formula II as described herein, or a salt thereof, under simultaneous or sequential condensation and cyclisation conditions with an aniline compound of the formula III, wherein R2 and m are as defined for a compound of the formula I. Further reactions and related embodiments are also claimed and disclosed.

Abstract: A method for treating a patient suffering from disorders and deficits of the central nervous system associated with diabetes, associated with aging and neurodegeneration, comprising attention deficit disorder in general, attention deficit hyperactivity disorder (ADHD), Alzheimer's disease (AD), mild cognitive impairment, senile dementia, AIDS dementia, neurodegeneration, depression, and schizophrenia, comprising administering to a patient in need of such treatment an effective amount of a selective inhibitor of the 11-?-hydroxysteroid dehydrogenase Type 1 enzyme activity.

Abstract: The present invention relates to compounds which inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II diabetes, as well as hyperglycemia, Syndrome X, hyperinsulinemia, obesity, atherosclerosis, and various immunomodulatory diseases.

Abstract: The present invention relates to inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids.

Abstract: There is described a new polymorphic form of 4-(7-Hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile and a method of preparing it.

Abstract: Disclosed is a rack driving-type power assisted steering apparatus having effects of preventing a lock screw from being loosened due to vibration in axial and radial directions generated by a rack bar, a ball nut, and a rack housing when the rack bar slides while the ball nut rotates, reducing vibration and noise of the ball nut and the rack bar transferred through a bearing, and providing a driver with steering comfortability.